share_log

翰森製藥：截至二零二三年十二月三十一日止年度之末期股息

HANSOH PHARMA: FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2023

香港交易所 ·  Mar 26 06:35
Summary by Moomoo AI
翰森製藥集團有限公司（股份代號：03692）於2024年3月26日宣布，將為截至2023年12月31日的財政年度末期派發普通股息，每股股息為0.1422港元。股東批准日期尚待公佈。股息除淨日定於2024年6月19日，而股份過戶登記的最後時限為2024年6月20日下午4時30分。股份過戶登記將於2024年6月21日至25日暫停，記錄日期為2024年6月25日，股息派發日則訂於2024年7月17日。此外，公司發行的600百萬美元二零二六年到期的零息可換股債券（股份代號：40546）持有人，若欲享有股息權利，須於2024年6月20日下午4時30分前行使轉換權。公司董事會成員包括主席兼執行董事鍾慧娟女士、執行董事呂愛鋒先生及孫遠女士；及獨立非執行董事林國強先生、陳尚偉先生及楊東濤女士。
翰森製藥集團有限公司（股份代號：03692）於2024年3月26日宣布，將為截至2023年12月31日的財政年度末期派發普通股息，每股股息為0.1422港元。股東批准日期尚待公佈。股息除淨日定於2024年6月19日，而股份過戶登記的最後時限為2024年6月20日下午4時30分。股份過戶登記將於2024年6月21日至25日暫停，記錄日期為2024年6月25日，股息派發日則訂於2024年7月17日。此外，公司發行的600百萬美元二零二六年到期的零息可換股債券（股份代號：40546）持有人，若欲享有股息權利，須於2024年6月20日下午4時30分前行使轉換權。公司董事會成員包括主席兼執行董事鍾慧娟女士、執行董事呂愛鋒先生及孫遠女士；及獨立非執行董事林國強先生、陳尚偉先生及楊東濤女士。
HANSEN PHARMACEUTICAL GROUP LIMITED (STOCK CODE: 03692) ANNOUNCED ON 26 MARCH 2024 THAT IT WILL DISTRIBUTE AN ORDINARY DIVIDEND OF HK$0.1422 PER SHARE FOR THE END OF THE FISCAL YEAR ENDED 31 DECEMBER 2023. Shareholders' approval date is expected to be announced. The net dividend distribution date is set for June 19, 2024, and the closing date for share transfer registration is 4:30pm on June 20, 2024. Share transfer registration will be suspended from 21 June to 25 June 2024 with a record date of 25 June 2024, and the dividend distribution date is set for 17 July 2024. In addition, holders of $600 million of the Company's issued Zero-Dividend Convertible Notes (Stock Code: 40546) maturing in 2006 are required to exercise the conversion right before 4:30 p.m. on June 20, 2024. The members of the Company's Board of Directors include Chairman and Executive Director Ms. Chung Wai Chuan, Executive Director Mr. Lui Aifeng and Ms. Sun Yuen; and Independent Non-Executive Directors Mr. Lin Guoqiang, Mr. Chan Shang Wei and Ms. Yang Tong Tao.
HANSEN PHARMACEUTICAL GROUP LIMITED (STOCK CODE: 03692) ANNOUNCED ON 26 MARCH 2024 THAT IT WILL DISTRIBUTE AN ORDINARY DIVIDEND OF HK$0.1422 PER SHARE FOR THE END OF THE FISCAL YEAR ENDED 31 DECEMBER 2023. Shareholders' approval date is expected to be announced. The net dividend distribution date is set for June 19, 2024, and the closing date for share transfer registration is 4:30pm on June 20, 2024. Share transfer registration will be suspended from 21 June to 25 June 2024 with a record date of 25 June 2024, and the dividend distribution date is set for 17 July 2024. In addition, holders of $600 million of the Company's issued Zero-Dividend Convertible Notes (Stock Code: 40546) maturing in 2006 are required to exercise the conversion right before 4:30 p.m. on June 20, 2024. The members of the Company's Board of Directors include Chairman and Executive Director Ms. Chung Wai Chuan, Executive Director Mr. Lui Aifeng and Ms. Sun Yuen; and Independent Non-Executive Directors Mr. Lin Guoqiang, Mr. Chan Shang Wei and Ms. Yang Tong Tao.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more